Feb 19 (Reuters) - Immunitybio Inc IBRX.O:
FDA AUTHORIZES IMMUNITYBIO TO PROVIDE RECOMBINANT BCG (RBCG) TO UROLOGISTS TO ADDRESS TICE® BCG SHORTAGE
IMMUNITYBIO INC: SUPPLIES OF RBCG ARE NOW AVAILABLE, WITH SHIPMENTS SET TO BEGIN IMMEDIATELY VIA AN FDA EXPANDED ACCESS PROGRAM
IMMUNITYBIO INC - THOUSANDS OF VIALS OF RBCG AVAILABLE TO END TICE BCG SHORTAGE
Source text: nBwc1xmZza
Further company coverage: IBRX.O